Jason Springs is currently the CEO of GeneWeave Biosciences, LLC. His company develops diagnostic devices that detect the presence and drug-resistance of disease-causing bacteria without the need for a diagnostic laboratory. The company is particularly focused on detecting so-called \"superbugs\" -disease-causing bacteria that are resistant or immune to standard antibiotics, as well as bacteria responsible for many hospital-acquired infections (HAIs). Jason Springs is a first year MBA student at the Johnson School at Cornell University. He received his undergraduate degree in Economics and Management from the University of South Carolina.
And this comes down to just some pretty simple things. And this isn't just a U.S. healthcare talk, by the way. This is global. The patients rarely understand what they're getting, despite our access to WebMD. The people that actually know what they're doing, hopefully, they never actually pay fo...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login
